Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lijin Li

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Alzheimer'S Disease : JAD|April 7, 2026
Changes in frailty and its association with dementia risk in four prospective cohortsXinxin Luo, Haoran Li, Yan Yu, et al.
Cancer Gene Therapy|December 16, 2017
Development of an adenovirus vector vaccine platform for targeting dendritic cellsPiyush K Sharma, Igor P Dmitriev, Elena A Kashentseva, et al.
Nature|April 15, 2026
mRNA vaccines engage unconventional pathways in CD8<sup>+</sup> T cell primingSuin Jo, Lijin Li, Chandrani Thakur, et al.
Nature|August 14, 2020
cDC1 prime and are licensed by CD4<sup>+</sup> T cells to induce anti-tumour immunityStephen T Ferris, Vivek Durai, Renee Wu, et al.
Cancer Immunology, Immunotherapy : CII|May 13, 2023
Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiologyUsman Y Panni, Michael Y Chen, Felicia Zhang, et al.
Cancer Immunology Research|February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trialRashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.
Genome Medicine|April 21, 2021
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translationLijin Li, Xiuli Zhang, Xiaoli Wang, et al.
Cancer Immunology Research|June 17, 2017
Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor ImmunityXiuli Zhang, Samuel Kim, Jasreet Hundal, et al.
Genome Medicine|November 14, 2024
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patientsXiuli Zhang, S Peter Goedegebuure, Michael Y Chen, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Alzheimer'S Disease : JAD|April 7, 2026
Changes in frailty and its association with dementia risk in four prospective cohortsXinxin Luo, Haoran Li, Yan Yu, et al.
Cancer Gene Therapy|December 16, 2017
Development of an adenovirus vector vaccine platform for targeting dendritic cellsPiyush K Sharma, Igor P Dmitriev, Elena A Kashentseva, et al.
Nature|April 15, 2026
mRNA vaccines engage unconventional pathways in CD8<sup>+</sup> T cell primingSuin Jo, Lijin Li, Chandrani Thakur, et al.
Nature|August 14, 2020
cDC1 prime and are licensed by CD4<sup>+</sup> T cells to induce anti-tumour immunityStephen T Ferris, Vivek Durai, Renee Wu, et al.
Cancer Immunology, Immunotherapy : CII|May 13, 2023
Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiologyUsman Y Panni, Michael Y Chen, Felicia Zhang, et al.
Cancer Immunology Research|February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trialRashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.
Genome Medicine|April 21, 2021
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translationLijin Li, Xiuli Zhang, Xiaoli Wang, et al.
Cancer Immunology Research|June 17, 2017
Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor ImmunityXiuli Zhang, Samuel Kim, Jasreet Hundal, et al.
Genome Medicine|November 14, 2024
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patientsXiuli Zhang, S Peter Goedegebuure, Michael Y Chen, et al.
Pageof 3